New York, NY -- (SBWIRE) -- 03/10/2017 -- Hemofiltration Machines Market: Drivers and Challenges

Increased hospitalization rates and incidence of acute kidney failure in intensive care units are the major factors driving the growth of global hemofiltration machines market over the forecast period. Moreover, expanding cases of major causes for acute kidney failure such as incidence of diabetes mellitus, metabolic acidosis, etc. are also expected to boost the global market for hemofiltration machines. For instance, in the U.S., approximately 2-5% of patients admitted to hospital develop acute kidney failure. Understanding of pathophysiology of acute renal failure has made significant contribution in development of advanced renal replacement therapy techniques such as hemofiltration. However, high price of the machines is the major restraint for the growth of global hemofiltration systems market.

Hemofiltration Machines Market: Key Players

Some of the major players in global hemofiltration systems market are Baxter Healthcare Corporation, Fresenius Medical Care AG & Co. KGaA, INFOMED SA, etc.

A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/14356

Hemofiltration Machines Market: Regional Overview

On the basis of regional presence, global hemofiltration machines market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America will continue to dominate the global hemofiltration machines market for due to high incidence of acute kidney failure. Europe is expected to hold second largest market share in global hemofiltration machines market. In developed countries, there is a high incidence of intensive care unit-acquired acute kidney failure, whereas in developing countries there is a high incidence of community-acquired acute kidney failure.

To View TOC of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/toc/14356